Skip to content
Research Article Open access CC BY 4.0

Risk Factors and Mechanism of Hemorrhagic Transformation of Acute Ischemic Cerebral Infarction

Omotola Akinade, Gabriel Alugba, Chidinma Chukwudum, Alexsandra Urhi, Adewale Mark Adedoyin, Funmilola Babalola, Ayobami Adesuyi, Favour David, Obiamaka Pamela Okereke, Abimbola Eunice Arisoyin, Benedicta Kolajo, Ojali Ruth Unedu, Adeyinka Aladejare, Aduwa Oboasekhi, Gibson O. Anugwom

Journal of Advances in Medicine and Medical Research · pp. 108–120 · Published 11 Aug 2022

10.9734/jammr/2022/v34i2131529

Abstract

A feared complication of ischemic cerebrovascular accident (CVA) is hemorrhagic transformation and it increases the length of hospital admissions, results in poor clinical outcomes and increases mortality. This study aims to identify risk factors of hemorrhagic transformation, discuss the pathogenesis of transformation and prognosis of the condition from original studies conducted within the past 10 years. PubMed and EMBASE are the major databases used. Eight articles met the inclusion criteria and are a mixture of retrospective and prospective studies. The sample size ranges from 32 to 1484 patients. Generally, the mechanism of hemorrhagic transformation identified involves the release of reactive oxygen species and metalloproteinase as a result of cerebral ischemia. Metalloproteinase further causes a breakdown of the extracellular matrix, thereby giving rise to the extravasation of cellular components. Some identified risk factors include: age, use of antithrombotic, the subtype of ischemic stroke, the severity of stroke and hypertension. Prognosis is linked to the type of hemorrhagic infarctions according to the European Cooperative Acute Stroke Study II (ECASS II) with patients with either hemorrhagic infarct type 2 (HI2) and parenchymal hematoma type 2 (PH2) having the worst functional outcome.

Hemorrhagic transformation acute ischemic cerebral infarction cerebrovascular accident risk factors

Cited by 2

Role of Nanotechnology in Ischemic Stroke: Advancements in Targeted Therapies and Diagnostics for Enhanced Clinical Outcomes

Virendra Kumar Yadav, Rachna Gupta, Abdullah A. Assiri · Journal of Functional Biomaterials · 2025

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

2

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.